TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11164694

Group type: EXPERIMENTAL
Intervention: Escalating voucher incentive schedule
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-incentive schedule
Number of subjects: 80
Study: 9569659

Group type: EXPERIMENTAL
Intervention: Subclinically depressed group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Nondepressed control group
Number of subjects: 75
Study: 8149503

Group type: EXPERIMENTAL
Intervention: Methylphenidate (Ritalin)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Antecedent exercise
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 3170699

Group type: EXPERIMENTAL
Intervention: RU486 (mifepristone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31611264

Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (DMF)
Number of subjects: 52
Study: 29231474

Group type: EXPERIMENTAL
Intervention: Warm acupuncture at Zhongwan (CV 12)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional acupuncture (twirling reinforcing at Zhongwan (CV 12))
Number of subjects: 62
Study: 25595138

Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day) + inhaled beclometasone (400 μg/day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Inhaled beclometasone (400 μg/day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Atorvastatin + inhaled beclometasone
Number of subjects: 39
Study: 24170120

Group type: EXPERIMENTAL
Intervention: Perpendicular incision (group 2)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Parallel incision (group 1)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 21828967

Group type: COMPARATOR
Intervention: Control group (education only)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 2% mupirocin ointment applied to the nares twice daily
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intranasal mupirocin plus daily 4% chlorhexidine body washes
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intranasal mupirocin plus daily dilute bleach water baths
Number of subjects: 300
Study: 20057901

Group type: EXPERIMENTAL
Intervention: Xience V everolimus-eluting stent
Number of subjects: 3
Study: 17134636

Group type: EXPERIMENTAL
Intervention: n-3 FA supplementation (1 to 3.4 g/day) for 4 to 6 months
Number of subjects: 18
Study: 15181294

Group type: EXPERIMENTAL
Intervention: Fast advancement (30 ml/kg/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Slow advancement (15 ml/kg/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 53
Study: 11275937

Group type: EXPERIMENTAL
Intervention: ioxaglate 320
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: iodixanol 320
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: iopamidol 340
Number of subjects: 2001
Study: 9402453

Group type: EXPERIMENTAL
Intervention: Temperature-controlled radiofrequency catheter ablation
Number of subjects: 69

Group type: COMPARATOR
Intervention: Manually delivered radiofrequency catheter ablation
Number of subjects: 69
Study: 7587605

Group type: EXPERIMENTAL
Intervention: Hirudo treatment
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 31
Study: 2146242

Group type: EXPERIMENTAL
Intervention: 2 g spectinomycin (single intramuscular injection)
Number of subjects: 55

Group type: COMPARATOR
Intervention: 500 mg erythromycin base (five-day oral course, three times daily)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 2 g spectinomycin
Number of subjects: 55
Study: 657032

Group type: EXPERIMENTAL
Intervention: Topical aerosol spray containing neomycin sulfate, polymyxin B sulfate and zinc bacitracin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 100
Study: 31915035

Group type: EXPERIMENTAL
Intervention: Visual intervention program (starting at 1 year CA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo treatment (control group starting at 2 years CA)
Number of subjects: 100
Study: 30670238

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (n = 41), 90-minute sessions of physical, cognitive, or social activities twice weekly
Number of subjects: 83

Group type: COMPARATOR
Intervention: Health education control group (n = 42)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (n = 41)
Number of subjects: 83
Study: 28093370

Group type: EXPERIMENTAL
Intervention: Lokomat
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: G-EO
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: PBWSTT
Number of subjects: 22
Study: 25749543

Group type: EXPERIMENTAL
Intervention: Dexamethasone sodium phosphate (DSP) cream applied to the right ear for 15 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo-water in oil emulsion type cream applied to the left ear for 15 days
Number of subjects: 32
Study: 24535377

Group type: COMPARATOR
Intervention: β-blocker therapy
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: ivabradine therapy
Number of subjects: 14
Study: 22763622

Group type: EXPERIMENTAL
Intervention: Standardized psychosocial stress procedure (Trier Social Stress Test)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 71
Study: 20593433

Group type: EXPERIMENTAL
Intervention: Voluntary health insurance program
Number of subjects: 0
Study: 18274218

Group type: EXPERIMENTAL
Intervention: Two-test condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: One-test condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Speeded-response key-pressing tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential-timing tasks
Number of subjects: 0
Study: 15807926

Group type: EXPERIMENTAL
Intervention: Endocrine agents like aromatase inhibitors and luteinizing hormone-releasing hormone agonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potent bisphosphonates
Number of subjects: 0
Study: 11851906

Group type: EXPERIMENTAL
Intervention: IFN‐alpha2a, ribavirin and amantadine
Number of subjects: 2
Study: 10447136

Group type: EXPERIMENTAL
Intervention: Infants of mothers who smoked and consumed alcohol during pregnancy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Infants of mothers who abstained from both alcohol and smoking
Number of subjects: 40
Study: 8690815

Group type: EXPERIMENTAL
Intervention: 5 mg twice daily of befloxatone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg once daily of befloxatone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2071841

Group type: EXPERIMENTAL
Intervention: Ability training
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Extended retest practice
Number of subjects: 116
Study: 6862626

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30554263

Group type: EXPERIMENTAL
Intervention: Relapsed ependymoma (n = 13)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Non-relapsing ependymoma (n = 16)
Number of subjects: 44
Study: 27888435

Group type: EXPERIMENTAL
Intervention: Ma-Pi2 macrobiotic diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control diet based on dietary guidelines for type 2 diabetes
Number of subjects: 40
Study: 25751300

Group type: EXPERIMENTAL
Intervention: Alpha-Lipoic Acid (ALA) 1200 mg/day for 8 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 70
Study: 24121698

Group type: EXPERIMENTAL
Intervention: Hawaiian‐based, self‐management intervention for reducing blood pressure and stress
Number of subjects: 0
Study: 20951527

Group type: EXPERIMENTAL
Intervention: Short-axis approach to ultrasound-guided peripheral intravenous access (USGPIV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Long-axis approach to ultrasound-guided peripheral intravenous access (USGPIV)
Number of subjects: 40
Study: 20027350

Group type: EXPERIMENTAL
Intervention: Anaferon (pediatric formulation)
Number of subjects: 0
Study: 17099514

Group type: EXPERIMENTAL
Intervention: 4 mL/kg 7.5% NaCl
Number of subjects: 15

Group type: COMPARATOR
Intervention: 4 mL/kg 0.9% NaCl
Number of subjects: 15

Group type: COMPARATOR
Intervention: 32 mL/kg 0.9% NaCl
Number of subjects: 15
Study: 14715354

Group type: EXPERIMENTAL
Intervention: Strenuous aerobic activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11758304

Group type: EXPERIMENTAL
Intervention: Telemonitored polysomnography (TMpsg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Home unattended polysomnography (Hpsg)
Number of subjects: 99
Study: 1407911

Group type: EXPERIMENTAL
Intervention: Expectant management plus antimicrobial therapy (intravenous ampicillin, gentamicin, and clindamycin for 24 hours, followed by amoxicillin plus clavulanic acid orally for 7 days.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Expectant management alone
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Expectant management plus antimicrobial therapy
Number of subjects: 94
Study: 3899506

Group type: EXPERIMENTAL
Intervention: IUD insertion immediately after abortion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IUD insertion (Nova T)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IUD insertion (Multiload 250)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IUD insertion (both types)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral contraception
Number of subjects: 0
Study: 30253776

Group type: EXPERIMENTAL
Intervention: Strength exercises embedded in physical education classes (15-30 min, 2x per week) plus monthly motivational lessons
Number of subjects: 695

Group type: COMPARATOR
Intervention: Control group following usual curriculum
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Strength exercises plus motivational lessons
Number of subjects: 695
Study: 27107680

Group type: EXPERIMENTAL
Intervention: Managing Cancer Care: A Personal Guide (MCC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Symptom Management Toolkit
Number of subjects: 60
Study: 24958355

Group type: EXPERIMENTAL
Intervention: Telehealth device (electronic pill box)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Smartphone app (m-health intervention)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reminders (from both interventions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Passive medication reminder devices (silent)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overall adherence
Number of subjects: 60
Study: 22837068

Group type: EXPERIMENTAL
Intervention: Supported Group (SG) with prone-positioning support and inflatable device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (CG) without support
Number of subjects: 40
Study: 20179697

Group type: EXPERIMENTAL
Intervention: Sodium picosulfate (SPS)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study: 19189674

Group type: EXPERIMENTAL
Intervention: Ultrasonic agitation during application of Clearfil S3 Bond
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ultrasonic agitation during application of Futurabond NR
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ultrasonic agitation during application of Clearfil SE Bond at priming
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ultrasonic agitation during application of Clearfil SE Bond at bonding
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group with Clearfil S3 Bond
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group with Futurabond NR
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group with Clearfil SE Bond
Number of subjects: 42
Study: 16157523

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (3 monthly courses)
Number of subjects: 23
Study: 14614794

Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Vigorous exercise
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Home-based exercise
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Centre-based exercise
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Self-efficacy for overcoming barriers
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Decisional balance
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Action to maintenance
Number of subjects: 115
Study: 10960225

Group type: EXPERIMENTAL
Intervention: TNO Test
Number of subjects: 115

Group type: COMPARATOR
Intervention: Titmus Stereotest Circles
Number of subjects: 115
Study: 8889084

Group type: EXPERIMENTAL
Intervention: Self-care manual for bulimia nervosa, duration: 8 weeks
Number of subjects: 100
Study: 1802636

Group type: EXPERIMENTAL
Intervention: Iron supplementation (66 mg elemental iron daily)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 4091151

Group type: EXPERIMENTAL
Intervention: VMS supplying the USRDA of all vitamins, zinc, iron, iodine, copper, and 60% of the USRDA of calcium, 50% of magnesium and 45% of phosphorus, consumed for 77 days.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo, consumed for 77 days.
Number of subjects: 42
Study: 30077119

Group type: EXPERIMENTAL
Intervention: Micronised progesterone (MP)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Dydrogesterone (DYD)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Low serum progesterone group
Number of subjects: 141
Study: 26847007

Group type: EXPERIMENTAL
Intervention: Physical therapist‐guided aerobic exercise
Number of subjects: 13
Study: 24903469

Group type: EXPERIMENTAL
Intervention: Screening for dementia using the Memory Impairment Screen Telephone version
Number of subjects: 4000

Group type: COMPARATOR
Intervention: No screening for dementia
Number of subjects: 4000
Study: 21846425

Group type: EXPERIMENTAL
Intervention: Reasoning and Rehabilitation (R&R) programme
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Reasoning and Rehabilitation (R&R) programme (completers)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 84
Study: 21516496

Group type: EXPERIMENTAL
Intervention: Conventional treatment + Tamsulosin (TAM)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional treatment + Placebo
Number of subjects: 65
Study: 17868403

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Glyceryltrinitrate (GTN)
Number of subjects: 180
Study: 16550369

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Intermittent mandatory ventilation
Number of subjects: 31
Study: 12890302

Group type: EXPERIMENTAL
Intervention: Amisulpride (100 mg b.i.d.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (bid)
Number of subjects: 24
Study: 10733058

Group type: EXPERIMENTAL
Intervention: 3% body weight vest
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 5% body weight vest
Number of subjects: 62

Group type: COMPARATOR
Intervention: No vest (control)
Number of subjects: 62
Study: 8606066

Group type: EXPERIMENTAL
Intervention: 0.8 ng of Salmonella abortus equi endotoxin per kg of body weight administered intravenously at 0900 h
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1533606

Group type: EXPERIMENTAL
Intervention: Isradipine (5 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Exercise (before ingestion of isradipine or placebo)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resting condition
Number of subjects: 18
Study: 6505988

Group type: EXPERIMENTAL
Intervention: Encouragement during walking tests
Number of subjects: 43
Study: 30260681

Group type: EXPERIMENTAL
Intervention: Enhanced sonification (tremolo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced sonification (tremolo plus brightness)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional sonification
Number of subjects: 0
Study: 29629988

Group type: EXPERIMENTAL
Intervention: Cerebral blood flow measured at a mean arterial pressure target of 65 mm Hg in septic patients
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Cerebral blood flow measured at a mean arterial pressure target of greater than or equal to 75 mm Hg in septic patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cerebral blood flow measured without sedation in control subjects
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cerebral blood flow measured with sedation in control subjects
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Cerebral blood flow in sedated septic patients (mean arterial pressure target 65 mm Hg)
Number of subjects: 22
Study: 26657819

Group type: EXPERIMENTAL
Intervention: Stereotype threat condition
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 55
Study: 25122647

Group type: EXPERIMENTAL
Intervention: Pregnant women consuming 57 μg of dietary biotin/d
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Lactating women consuming 57 μg of dietary biotin/d
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control women
Number of subjects: 75
Study: 23095631

Group type: EXPERIMENTAL
Intervention: TachoSil
Number of subjects: 275

Group type: COMPARATOR
Intervention: Standard surgical suturing or stapling
Number of subjects: 275
Study: 20171481

Group type: EXPERIMENTAL
Intervention: 10 mg morphine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 5 mg morphine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% (Carbostesin)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Isotonic saline solution (placebo)
Number of subjects: 48
Study: 17926825

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0
Study: 16221550

Group type: EXPERIMENTAL
Intervention: Mini‐ECC
Number of subjects: 136

Group type: COMPARATOR
Intervention: CPB
Number of subjects: 136
Study: 12710841

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (Seredrin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10022631

Group type: EXPERIMENTAL
Intervention: Formula UBT with 270 ml of mixed formula meal (1 Kcal/ml)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Water UBT with equivalent amount of tap water
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: L-DOPA pretreatment (500 mg given 30 min before [13C]-urea load)
Number of subjects: 115
Study: 8528429

Group type: EXPERIMENTAL
Intervention: Cost estimates for the intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline costs for the control group
Number of subjects: 0
Study: 2272718

Group type: EXPERIMENTAL
Intervention: 10 mg acenocoumarol in combination with cimetidine
Number of subjects: 9

Group type: COMPARATOR
Intervention: 10 mg acenocoumarol in combination with placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 10 mg acenocoumarol after one week pretreatment with pentobarbitone
Number of subjects: 9
Study: 7375236

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 31786651

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2400 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30384775

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Psychoanalytic therapy (PAT)
Number of subjects: 252
Study: 27803983

Group type: EXPERIMENTAL
Intervention: Two-handed jaw thrust
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single-handed chin lift
Number of subjects: 60
Study: 25909408

Group type: EXPERIMENTAL
Intervention: TXA
Number of subjects: 1032

Group type: COMPARATOR
Intervention: no-TXA
Number of subjects: 1032
Study: 23879213

Group type: EXPERIMENTAL
Intervention: Oral oxycodone prescribed, tailored dosing regimen; measured urine concentration 10 to 14 days after starting treatment.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Model for predicting oxycodone in urine.
Number of subjects: 20
Study: 21873632

Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg daily)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 19729161

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian diathermy (LOD)
Number of subjects: 126
Study: 16426958

Group type: EXPERIMENTAL
Intervention: Micronutrient-enriched beverage
Number of subjects: 869

Group type: COMPARATOR
Intervention: Placebo without added micronutrients
Number of subjects: 869
Study: 12627177

Group type: EXPERIMENTAL
Intervention: Black tea without milk
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Black tea with milk
Number of subjects: 10

Group type: COMPARATOR
Intervention: Black tea (both brands)
Number of subjects: 10
Study: 10688109

Group type: EXPERIMENTAL
Intervention: 82Rb PET
Number of subjects: 210

Group type: COMPARATOR
Intervention: Dual-isotope SPECT
Number of subjects: 210
Study: 9452696

Group type: EXPERIMENTAL
Intervention: Mouthwash based on triclosan
Number of subjects: 43

Group type: COMPARATOR
Intervention: Mouthwash based on chlorhexidine (positive control)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Mouthwash based on Zea mays L
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (negative control)
Number of subjects: 43
Study: 8363075

Group type: EXPERIMENTAL
Intervention: Desflurane at 1.0 MAC
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isoflurane at 1.0 MAC
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Desflurane at 1.5 MAC
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isoflurane at 1.5 MAC
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Desflurane at 1.25 MAC
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isoflurane at 1.25 MAC
Number of subjects: 24
Study: 3107493

Group type: EXPERIMENTAL
Intervention: Radionuclide angiocardiography
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ventriculography
Number of subjects: 36
Study: 31152308

Group type: EXPERIMENTAL
Intervention: iv methylprednisolone (20 mg b.i.d)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 29709383

Group type: EXPERIMENTAL
Intervention: e-learning resource (test group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: traditional didactic lecture (control group)
Number of subjects: 0